Article ID Journal Published Year Pages File Type
9182283 Revista Española de Cardiología Suplementos 2005 7 Pages PDF
Abstract
Cardiac resynchronization therapy has shown benefits in up to 70% of patients with left ventricular dysfunction and left bundle branch block. The availability in the market of devices that are able to produce different atrioventricular or ventricular activation sequences will help optimize device effectiveness and, hence, improve the clinical responses of patients with heart failure. However, much has still to be learned about how they should be programmed, about the best methodology to use, and about their clinical efficacy. Here, we review the extent of current limitations to our knowledge.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, ,